Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00257894
Status:
TERMINATED
Last Update Posted:
2015-11-04
First Post:
2005-11-21
Brief Title:
Baclofen Effects on Smoking Urge and Withdrawal
Sponsor:
VA Office of Research and Development
Organization:
VA Office of Research and Development
Study Overview
Official Title:
Baclofen Effects on Smoking Urge and Withdrawal
Status:
TERMINATED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Enrollment was completed with insufficient sample size for publishable results
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether baclofen is effective in reducing smoking urge withdrawal and reinforcement in moderate to heavy cigarette smokers
Detailed Description:
OBJECTIVES The long-term objective of this research program is to improve treatments for tobacco smokers by investigating the effects of medications on self-reported and psychophysiological responses to smoking cues and on behavioral-economic measures of smoking reinforcement during a period of tobacco deprivation The specific objectives of the present application are to investigate the dose-response effects of baclofen a gamma-aminobutyric acid B agonist 1 on urge and withdrawal and 2 on the reinforcement value of smoking as measured by choices for puffs on cigarettes versus an alternative reinforcer among current smokers after 4 hours of smoking deprivation RESEARCH PLAN The study will use a randomized placebo-controlled between-subjects design with 64 smokers to investigate the effects of placebo and two doses 20 or 40 mgday of baclofen on urge to smoke and withdrawal and on choices for smoking versus money after 4 hours of deprivation METHODS Participants will be healthy people who smoke at least 10 cigarettes per day and who are motivated for future smoking cessation On Day 0 a baseline session will occur after 4 hours of smoking deprivation and on Day 10 of medication the same assessments will be repeated after the final medication dose has been stabilized for at least 3 days and after 4 hours of supervised smoking deprivation has occurred Medication differences in urge and withdrawal and in the reinforcement value of smoking cigarettes will be investigated Dependent measures of urge and withdrawal will be by self-report The dependent measure of reinforcement value is the ratio of choices for cigarette puffs versus money during a subsequent 2-12 hr period The choice procedure will clarify the relative reinforcement value of smoking while controlling for non-specific decreases in general activity level resulting from sedation Nicotine self-administration during the medication period will be quantified using saliva cotinine as a secondary effect CLINICAL RELEVANCE More effective interventions for tobacco use could result in less suffering and mortality and in considerable savings in health care costs associated with cardiovascular disease pulmonary disorders and cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None